Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
gene editing
6
×
life sciences
national blog main
boston blog main
boston top stories
crispr
san francisco blog main
boston
editas medicine
national top stories
san francisco top stories
allergan
clinical trials
cynthia collins
deals
enzyme
sangamo therapeutics
abbvie
administration
agios therapeutics
alzheimer's
alzheimer's disease
amgen
base editing
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakpoint therapeutics
broad institute
cancer
car-t
cas13
celgene
celyad
clinical study
What
gene
6
×
editing
medicine
editas
crispr
experimental
humans
therapeutics
therapy
trial
abbvie
allergan
alliance
beam
becker
benefit
billions
bio
biotech
blessing
bosley
breathing
cas
ceo
check
clinical
close
colossal
companies
company
create
crispr’s
cusp
depart
dollars
eaton
editor
exits
founders
genetic
Language
unset
Current search:
gene
×
biotech
×
" gene editing "
×
@techcrunch.com
2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M